BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.500
+0.100 (2.27%)
Feb 21, 2025, 4:00 PM EST - Market closed
BioAge Labs Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for BioAge Labs stock have an average target of 18, with a low estimate of 7.00 and a high estimate of 40. The average target predicts an increase of 300.00% from the current stock price of 4.50.
Analyst Consensus: Hold
* Price targets were last updated on Dec 9, 2024.
Analyst Ratings
The average analyst rating for BioAge Labs stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $45 → $7 | Strong Buy → Hold | Downgrades | $45 → $7 | +55.56% | Dec 9, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $42 → $7 | Strong Buy → Hold | Downgrades | $42 → $7 | +55.56% | Dec 9, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +900.00% | Oct 21, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +788.89% | Oct 21, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +833.33% | Oct 21, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.71
from -38.17
EPS Next Year
-3.06
from -3.71
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.86 | -2.73 | -1.79 |
| Avg | -3.71 | -3.06 | -3.04 |
| Low | -5.19 | -3.20 | -4.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.